Journal Article

The dystroglycan receptor maintains glioma stem cells in the vascular niche

Bhat, Krishna P L, Rochelle C J D’Souza, Li, Yuchen, Stringer, Brett W, Po-Ling Inglis, Johns, Terrance G, Smith, Fiona M, Jeffree, Rosalind L, Day, Bryan W, Lwin, Zarnie, Baumgartner, Ulrich, Rich, Jeremy N, Ensbey, Kathleen S, Robertson, Thomas, Campbell, Kevin P, Lathia, Justin D, Akgül, Seçkin, Jamieson, Paul R, Jurd, Courtney L R, Lim, Yi Chieh, Offenhäuser, Carolin, Boyd, Andrew W, Bruce, Zara C

2019

Overview

Glioblastomas (GBMs) are malignant central nervous system (CNS) neoplasms with a very poor prognosis. They display cellular hierarchies containing self-renewing tumourigenic glioma stem cells (GSCs) in a complex heterogeneous microenvironment. One proposed GSC niche is the extracellular matrix (ECM)-rich perivascular bed of the tumour. Here, we report that the ECM binding dystroglycan (DG) receptor is expressed and functionally glycosylated on GSCs residing in the perivascular niche. Glycosylated αDG is highly expressed and functional on the most aggressive mesenchymal-like (MES-like) GBM tumour compartment. Furthermore, we found that DG acts to maintain an MES-like state via tight control of MAPK activation. Antibody-based blockade of αDG induces robust ERK-mediated differentiation leading to reduced GSC potential. DG was shown to be required for tumour initiation in MES-like GBM, with constitutive loss significantly delaying or preventing tumourigenic potential in-vivo. These findings reveal a central role of the DG receptor, not only as a structural element, but also as a critical factor promoting MES-like GBM and the maintenance of GSCs residing in the perivascular niche.

• Publisher: Springer Nature B.V
• Subject: Central nervous system / Dystroglycan / Extracellular matrix / Glioma / Glioma cells / MAP kinase / Mesenchyme / Stem cells / Tumors